HLA alleles associated with asparaginase hypersensitivity in Chinese children

J Hematol Oncol. 2021 Oct 30;14(1):182. doi: 10.1186/s13045-021-01201-3.

Abstract

Asparaginase is an important drug to treat childhood haematological malignancies. Data on the association between human leukocyte antigens (HLA) and asparaginase hypersensitivity among Chinese are lacking. We conducted a retrospective study to identify HLA alleles associated with asparaginase hypersensitivity among Chinese children with acute lymphoblastic leukaemia (ALL), mixed phenotype leukaemia and non-Hodgkin lymphoma (NHL), who received asparaginases with HLA typing performed between 2009 and 2019. 107 Chinese patients were analysed. 66.3% (71/107) developed hypersensitivity to at least one of the asparaginases. HLA-B*46:01 (OR 3.8, 95% CI 1.4-10.1, p < 0.01) and DRB1*09:01 (OR 4.3, 95% CI 1.6-11.4, p < 0.01) were significantly associated with L-asparaginase hypersensitivities, which remained significant after adjustment for age, gender and B cell ALL [HLA-B*46:01 (adjusted OR 3.5, 95% 1.3-10.5, p = 0.02) and DRB1*09:01 (OR 4.4, 95% CI 1.6-13.3, p < 0.01)].

Keywords: Allergy; Asparaginase; Children; Chinese; Human leukocyte antigens; Hypersensitivity.

Publication types

  • Letter

MeSH terms

  • Alleles
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Asian People / genetics
  • Asparaginase / adverse effects*
  • Asparaginase / therapeutic use
  • Child
  • Child, Preschool
  • China / epidemiology
  • Drug Hypersensitivity / etiology
  • Drug Hypersensitivity / genetics*
  • Female
  • Genetic Predisposition to Disease
  • HLA Antigens / genetics*
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Retrospective Studies

Substances

  • Antineoplastic Agents
  • HLA Antigens
  • Asparaginase